Literature DB >> 18606884

Wnt signaling: bone's defense against myeloma.

Claire M Edwards1.   

Abstract

Entities:  

Year:  2008        PMID： 18606884     DOI： 10.1182/blood-2008-04-149278

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  4 in total

1.  USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.

Authors:  Zesen Shang; Jiao Zhao; Qi Zhang; Cheng Cao; Shanshan Tian; Kai Zhang; Ling Liu; Lei Shi; Na Yu; Shangda Yang
Journal:  J Biol Chem       Date:  2019-05-09       Impact factor: 5.157

Review 2.  The role of Dickkopf-1 in bone development, homeostasis, and disease.

Authors:  Joseph J Pinzone; Brett M Hall; Nanda K Thudi; Martin Vonau; Ya-Wei Qiang; Thomas J Rosol; John D Shaughnessy
Journal:  Blood       Date:  2008-08-07       Impact factor: 22.113

3.  Genetic polymorphisms of EPHX1, Gsk3beta, TNFSF8 and myeloma cell DKK-1 expression linked to bone disease in myeloma.

Authors:  B G M Durie; B Van Ness; C Ramos; O Stephens; M Haznadar; A Hoering; J Haessler; M S Katz; G R Mundy; R A Kyle; G J Morgan; J Crowley; B Barlogie; J Shaughnessy
Journal:  Leukemia       Date:  2009-08-06       Impact factor: 11.528

4.  A virtual approach to evaluate therapies for management of multiple myeloma induced bone disease.

Authors:  Bing Ji; Paul G Genever; Michael J Fagan
Journal:  Int J Numer Method Biomed Eng       Date:  2015-09-02       Impact factor: 2.747
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.